UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Award Lecture Evolution of long-term adjuvant anti-hormone therapy: Consequences and opportunities

Breast (Edinburgh), 2011, Vol.20, p.S1-S1

Jordan, V.C

2011

Volltextzugriff (PDF)

Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal

Journal of steroid biochemistry and molecular biology, 2005-02, Vol.94 (1), p.131-141

2005

Volltextzugriff (PDF)

S29 Optimizing treatment and prevention of breast cancer: Time for a change?

Breast (Edinburgh), 2007, Vol.16, p.S9-S9

Jordan, V.C

2007

Volltextzugriff (PDF)

Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer

Oncogene, 2013-07, Vol.32 (27), p.3274-3285

2013

Volltextzugriff (PDF)

O-097. Action of oestrogens and their antagonists on target organs

Human reproduction (Oxford), 1997-06, Vol.12 (Suppl_2), p.46-46

Jordan, V.C

1997

Volltextzugriff (PDF)

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250mg With Fulvestrant 500mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer

Breast diseases, 2012-01, Vol.23 (2), p.190-191

Jordan, V.C.

2012

Volltextzugriff (PDF)

The pharmacology and clinical uses of tamoxifen

Pharmacology & therapeutics (Oxford), 1984, Vol.25 (2), p.127-205

1984

Volltextzugriff (PDF)

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study

Breast diseases, 2009-01, Vol.20 (1), p.95-96

Jordan, V.C.

2009

Volltextzugriff (PDF)

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study: DeMichele A, Troxel AB, Berlin JA, et al (Univ of Pennsylvania; Abramson Cancer Ctr, PA; Children's Hosp of Philadelphia, PA; et al) J Clin Oncol 26:4151-4159, 2008

Breast diseases, 2009, Vol.20 (1), p.95-96

Jordan, V.C.

2009

Volltextzugriff (PDF)

S37 Endocrine Therapies in the Future: Will an Old Dog Learn New Tricks?

Breast (Edinburgh), 2005-02, Vol.14, p.S14-S14

Jordan, V.C.

2005

Volltextzugriff (PDF)

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer: Di Leo A, Jerusalem G, Petruzelka L, et al (Hosp of Prato, Italy; Centre Hospitalier Universitaire Sart Tilman, Liége, Belgium; AZ. Klina, Brasschaat, Belgium; et al) J Clin Oncol 28:4594-4600, 2010

Breast diseases, 2012, Vol.23 (2), p.190-191

Jordan, V.C.

2012

Volltextzugriff (PDF)

2–39 Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

Breast diseases, 2005-07, Vol.16 (2), p.183-183

Jordan, V.C.

2005

Volltextzugriff (PDF)

Effects of low dose tamoxifen on normal breast tissue from premenopausal women

European journal of cancer (1990), 2003-05, Vol.39 (7), p.891-898

2003

Volltextzugriff (PDF)

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

European journal of cancer, 1976-06, Vol.12 (6), p.419-424

Jordan, V.C.

1976

Volltextzugriff (PDF)

S26 The molecular biology of the estrogen receptor (ER) aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifene

European journal of cancer (1990), 1998-02, Vol.34, p.S6-S7

Jordan, V.C.

1998

Volltextzugriff (PDF)

Subcellular compartmentalization of MCF-7 estrogen receptor synthesis and degradation

Molecular and cellular endocrinology, 1993-08, Vol.94 (2), p.183-194

1993

Volltextzugriff (PDF)

Selective oestrogen receptor modulation

European journal of cancer (1990), 1999-12, Vol.35 (14), p.1974-1985

1999

Volltextzugriff (PDF)

Selective oestrogen receptor modulation

European journal of cancer (1990), 1999-11, Vol.35 (12), p.1628-1639

1999

Volltextzugriff (PDF)

Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus

Molecular and cellular endocrinology, 1982-08, Vol.27 (3), p.291-306

1982

Volltextzugriff (PDF)

Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells

The Journal of biological chemistry, 1994-06, Vol.269 (24), p.16896-16901

1994

Volltextzugriff (PDF)

Targeting antihormone resistance in breast cancer: a simple solution

Annals of oncology, 2003-07, Vol.14 (7), p.969-970

Jordan, V C

2003

Volltextzugriff (PDF)

Regulation of Estrogen Target Genes and Growth by Selective Estrogen-Receptor Modulators in Endometrial Cancer Cells

Gynecologic oncology, 2002-06, Vol.85 (3), p.498-506

2002

Volltextzugriff (PDF)

What if tamoxifen (ICI 46,474) had been found to produce rat liver tumors in 1973?

Annals of oncology, 1995-01, Vol.6 (1), p.29-34

Jordan, V.C.

1995

Volltextzugriff (PDF)

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

European journal of cancer (1990), 1996-08, Vol.32 (9), p.1464-1476

1996

Volltextzugriff (PDF)

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

European journal of cancer (1990), 1994, Vol.30 (11), p.1714-1721

1994

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(95)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Award Lecture Evolution of long-term adjuvant anti-hormone therapy: Consequences and opportunities

Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal

S29 Optimizing treatment and prevention of breast cancer: Time for a change?

Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer

O-097. Action of oestrogens and their antagonists on target organs

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250mg With Fulvestrant 500mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer

The pharmacology and clinical uses of tamoxifen

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study: DeMichele A, Troxel AB, Berlin JA, et al (Univ of Pennsylvania; Abramson Cancer Ctr, PA; Children's Hosp of Philadelphia, PA; et al) J Clin Oncol 26:4151-4159, 2008

S37 Endocrine Therapies in the Future: Will an Old Dog Learn New Tricks?

2–39 Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

Effects of low dose tamoxifen on normal breast tissue from premenopausal women

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

S26 The molecular biology of the estrogen receptor (ER) aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifene

Subcellular compartmentalization of MCF-7 estrogen receptor synthesis and degradation

Selective oestrogen receptor modulation

Selective oestrogen receptor modulation

Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus

Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells

Targeting antihormone resistance in breast cancer: a simple solution

Regulation of Estrogen Target Genes and Growth by Selective Estrogen-Receptor Modulators in Endometrial Cancer Cells

What if tamoxifen (ICI 46,474) had been found to produce rat liver tumors in 1973?

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

Suchergebnisse filtern